Cargando…

Use of CA15-3 for screening breast cancer: An antibody-lectin sandwich assay for detecting glycosylation of CA15-3 in sera

Elevated serum CA15-3 assessed by enzyme-linked immunosorbent assay (ELISA) has been considered a diagnostic marker of breast cancer. However, accumulating data indicate that the current ELISA system for detecting CA15-3, which targets the peptide backbone of CA15-3, is not sufficiently sensitive to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Jae Woong, Moon, Byung-In, Lee, Jun Woo, Kim, Hyoung Jin, Jin, Yingji, Kim, Hong-Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059737/ https://www.ncbi.nlm.nih.gov/pubmed/29749490 http://dx.doi.org/10.3892/or.2018.6433

Ejemplares similares

Lectin nanoparticle assays for detecting breast cancer-associated glycovariants of cancer antigen 15-3 (CA15-3) in human plasma
por: Terävä, Joonas, et al.
Publicado: (2019)

Prognostic Impact of Elevation of Cancer Antigen 15-3 (CA15-3) in Patients With Early Breast Cancer With Normal Serum CA15-3 Level
por: Ryu, Jai Min, et al.
Publicado: (2023)

Serum CA 15-3 assay in the diagnosis and follow-up of breast cancer.
por: Kallioniemi, O. P., et al.
Publicado: (1988)

Evaluation of a newly developed quantitative determination kit for tumor marker CA15‐3 with chemiluminescent assay
por: Li, Peihua, et al.
Publicado: (2017)

Serum CA549 in primary breast cancer: comparison with CA15.3 and MCA.
por: Gion, M., et al.
Publicado: (1994)

Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases
por: Nicolini, Andrea, et al.
Publicado: (2006)

A Panel of CA19-9, Ca125, and Ca15-3 as the Enhanced Test for the Differential Diagnosis of the Pancreatic Lesion
por: Hogendorf, Piotr, et al.
Publicado: (2017)

Correlation of cancer antigen 15-3 (CA15-3) serum level and bony metastases in breast cancer patients
por: Fakhari, Ashraf, et al.
Publicado: (2019)

Circulating CA 15-3 antigen levels in non-mammary malignancies.
por: Colomer, R., et al.
Publicado: (1989)

Value of CA 15:3 in the follow-up of breast cancer patients.
por: Pons-Anicet, D. M., et al.
Publicado: (1987)

An evaluation of preoperative CA 15-3 measurement in primary breast carcinoma.
por: O'Hanlon, D. M., et al.
Publicado: (1995)

The utility of tumor markers CA 125, CA 15-3, and CA 19-9 in assessing the response to therapy in pulmonary and pleural tuberculosis
por: Tascı, Canturk, et al.
Publicado: (2012)

Diagnostic Value of Neuron-Specific Enolase (NSE) and Cancer Antigen 15-3 (CA 15-3) in the Diagnosis of Pleural Effusions
por: Saba, Mohammad Ali, et al.
Publicado: (2017)

Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C
por: ASSMAR, Mehdi, et al.
Publicado: (2016)

Carbon Nanopowder-Based Stochastic Sensor for Ultrasensitive Assay of CA 15-3, CEA and HER2 in Whole Blood
por: Stefan-van Staden, Raluca-Ioana, et al.
Publicado: (2022)

Serum CEA and CA 15-3 as prognostic factors in primary breast cancer
por: Ebeling, F G, et al.
Publicado: (2002)

CA 15-3 prognostic biomarker in SARS-CoV-2 pneumonia
por: Ros-Lucas, José Antonio, et al.
Publicado: (2022)

Detection of secondary metastatic breast cancer by measurement of plasma CA 15.3
por: De Cock, L., et al.
Publicado: (2021)

Nipple Discharge of CA15-3, CA125, CEA and TSGF as a New Biomarker Panel for Breast Cancer
por: Wang, Gangping, et al.
Publicado: (2014)

A Giant Simple Liver Cyst That Caused Increases in Serum CA 19-9 and CA 15-3 Levels
por: Dinc, Bulent, et al.
Publicado: (2014)

Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in Relation to Ovarian Cancer Risk and Survival
por: Williams, Kristina A., et al.
Publicado: (2014)

Diagnostic Utility of Combined CEA, CA15-3 and CA125 Biomarkers and Cytomorphology in Suspicious and Malignant Serosal Fluid
por: Rahemi, Zahra, et al.
Publicado: (2021)

Application of an enzyme-linked immunosorbent assay for detection of antibodies to Actinobacillus pleuropneumoniae serovar 15 in pig sera
por: TESHIMA, Kaho, et al.
Publicado: (2017)

Menstrual Cycle Dependent Variability for Serum Tumor Markers CEA, AFP, CA 19-9, CA 125 and CA 15-3 in Healthy Women
por: Erbağci, Ayşe Binnur, et al.
Publicado: (1999)

Diagnostic and Prognostic Role of Preoperative Circulating CA 15-3, CA 125, and Beta-2 Microglobulin in Renal Cell Carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2014)

GDF-15 enhances intracellular Ca(2+) by increasing Ca(v)1.3 expression in rat cerebellar granule neurons
por: Lu, Jun-Mei, et al.
Publicado: (2016)

Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance
por: Hing, J.X., et al.
Publicado: (2020)

Detection of distinct glycosylation patterns on human γ-glutamyl transpeptidase 1 using antibody-lectin sandwich array (ALSA) technology
por: West, Matthew B, et al.
Publicado: (2014)

CA15.3 Serum Concentrations in Older Women with Infiltrating Ductal Carcinomas of the Breast
por: Ruibal, Álvaro, et al.
Publicado: (2014)

Falsely Elevated CA 15-3 Levels in Ovarian Sarcoidosis with Peritoneal Involvement and Ascites
por: Tsiodras, Sotirios, et al.
Publicado: (2018)

Correlation between salivary and serum CA15-3 concentrations in patients with breast cancer
por: Assad, Daniele Xavier, et al.
Publicado: (2020)

Primary Cutaneous Mucinous Carcinoma Monitoring: A Role for CA15.3 and CEA?
por: Ginguay, Antonin, et al.
Publicado: (2022)

CA 15-3, CRP, and LDH correlates with prognostic parameters in canine mammary neoplasms
por: Pinheiro, Breno Queiroz, et al.
Publicado: (2023)

Diagnostic impact of CEA and CA 15-3 on chemotherapy monitoring of breast cancer patients
por: Hasan, Diya
Publicado: (2022)

Serum Levels and Glycosylation Changes of Alpha-1-Acid Glycoprotein According to Severity of Breast Cancer in Korean Women
por: Choi, Jae Woong, et al.
Publicado: (2020)

Exploring the Glycosylation of Serum CA125
por: Saldova, Radka, et al.
Publicado: (2013)

Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses
por: Park, Byung-Joon, et al.
Publicado: (2014)

Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment
por: Bartsch, Rupert, et al.
Publicado: (2006)

The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 cases.
por: Gion, M., et al.
Publicado: (1991)

Human gallbladder carcinoma: Role of neurotrophins, MIB-1, CD34 and CA15-3
por: Artico, M., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_dh9t3tc8ga6t26bjfseuujl0th